Baseline genotype testing to assess drug resistance before beginning HIV treatment

dc.contributor.author
Ambrosioni, Juan
dc.contributor.author
Mosquera, Maria Mar
dc.contributor.author
Miró Meda, José M. (José María), 1956-
dc.date.issued
2020-05-25T15:17:40Z
dc.date.issued
2020-05-25T15:17:40Z
dc.date.issued
2018-11-27
dc.date.issued
2020-05-25T15:17:40Z
dc.identifier
0098-7484
dc.identifier
https://hdl.handle.net/2445/162323
dc.identifier
687141
dc.identifier
30480719
dc.description.abstract
To the Editor
dc.format
2 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
American Medical Association
dc.relation
Reproducció del document publicat a: https://doi.org/10.1001/jama.2018.15926
dc.relation
JAMA-Journal of the American Medical Association, 2018, vol. 320, num. 20, p. 2153-2154
dc.relation
https://doi.org/10.1001/jama.2018.15926
dc.rights
(c) American Medical Association, 2018
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Antiretrovirals
dc.subject
Resistència als medicaments
dc.subject
Antiretroviral agents
dc.subject
Drug resistance
dc.title
Baseline genotype testing to assess drug resistance before beginning HIV treatment
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)